The purpose of this article is to assess the diagnostic performance of arterial spin-labeling (ASL) magnetic resonance perfusion imaging to differentiate neoplastic from non-neoplastic brain lesions.
Material and methods
This prospective study included 60 consecutive, newly diagnosed, untreated patients with intra-axial lesions with perilesional edema (PE) who underwent clinical magnetic resonance imaging including ASL sequences at 3T. Region of interest analysis was performed to obtain mean cerebral blood flow (CBF) values from lesion (L), PE and normal contralateral white matter (CWM). Normalized (n) CBF ratio was obtained by dividing the mean CBF value of L and PE by mean CBF value of CWM. Discriminant analyses were performed to determine the best cutoff value of nCBFL and nCBFPE in differentiating neoplastic from non-neoplastic lesions.
Results
Thirty patients were in the neoplastic group (15 high-grade gliomas (HGGs), 15 metastases) and 30 in the non-neoplastic group (12 tuberculomas, 10 neurocysticercosis, four abscesses, two fungal granulomas and two tumefactive demyelination) based on final histopathology and clincoradiological diagnosis. We found higher nCBFL (6.65 ± 4.07 vs 1.68 ± 0.80, p < 0.001) and nCBFPE (1.86 ± 1.43 vs 0.74 ± 0.21, p < 0.001) values in the neoplastic group than non-neoplastic. For predicting neoplastic lesions, we found an nCBFL cutoff value of 1.89 (AUC 0.917; 95% CI 0.854 to 0.980; sensitivity 90%; specificity 73%) and nCBFPE value of 0.76 (AUC 0.783; 95% CI 0.675 to 0.891; sensitivity 80%; specificity 58%). Mean nCBFL was higher in HGGs (8.70 ± 4.16) compared to tuberculomas (1.98 ± 0.87); and nCBFPE was higher in HGGs (3.06 ± 1.53) compared to metastases (0.86 ± 0.34) and tuberculomas (0.73 ± 0.22) (p < 0.001).
Conclusion
ASL perfusion may help in distinguishing neoplastic from non-neoplastic brain lesions.
OmuroAMLeiteCCMokhtariKet al.Pitfalls in the diagnosis of brain tumours. Lancet Neurol2006; 5: 937–948.
2.
LawMYangSBabbJSet al.Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol2004; 25: 746–755.
3.
WolfRLDetreJA. Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imaging. Neurotherapeutics2007; 4: 346–359.
4.
GradeMHernandez TamamesJAPizziniFBet al.A neuroradiologist’s guide to arterial spin labeling MRI in clinical practice. Neuroradiology2015; 57: 1181–1202.
5.
SoniNDhanotaDPSKumarSet al.Perfusion MR imaging of enhancing brain tumors: Comparison of arterial spin labeling technique with dynamic susceptibility contrast technique. Neurol India2017; 65: 1046–1052.
6.
JiangJZhaoLZhangYet al.Comparative analysis of arterial spin labeling and dynamic susceptibility contrast perfusion imaging for quantitative perfusion measurements of brain tumors. Int J Clin Exp Pathol2014; 7: 2790–2799.
7.
AtaESTurgutMEraslanCet al.Comparison between dynamic susceptibility contrast magnetic resonance imaging and arterial spin labeling techniques in distinguishing malignant from benign brain tumors. Eur J Radiol2016; 85: 1545–1553.
8.
ChaSLupoJMChenMHet al.Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol2007; 28: 1078–1084.
9.
LawMChaSKnoppEAet al.High-grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR imaging. Radiology2002; 222: 715–721.
10.
WeberMAZoubaaSSchlieterMet al.Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology2006; 66: 1899–1906.
11.
Bai Y, Shi D, Wang M, et al. Differentiation between glioblastomas and solitary brain metastases using pseudo-continuous arterial spin labeling perfusion MRI in peritumoral edema. European Congress of Radiology 2013, poster number C-2569.
GuptaRKHarisMHusainNet al.Relative cerebral blood volume is a measure of angiogenesis in brain tuberculoma. J Comput Assist Tomogr2007; 31: 335–341.
14.
SankheSBahetiAIhareAet al.Perfusion magnetic resonance imaging characteristics of intracerebral tuberculomas and its role in differentiating tuberculomas from metastases. Acta Radiol2013; 54: 307–312.
15.
ChatterjeeSSainiJKesavadasCet al.Differentiation of tubercular infection and metastases presenting as ring enhancing lesion by diffusion and perfusion magnetic resonance imaging. J Neuroradiol2010; 37: 167–171.
16.
HallerSZaharchukGThomasDLet al.Arterial spin labeling perfusion of the brain: Emerging clinical applications. Radiology2016; 281: 337–356.
17.
NoguchiTYakushijiYNishiharaMet al.Arterial spin-labeling in central nervous system infection. Magn Reson Med Sci2016; 15: 386–394.
18.
FlorianoVHTorresUSSpottiARet al.The role of dynamic susceptibility contrast-enhanced perfusion MR imaging in differentiating between infectious and neoplastic focal brain lesions: Results from a cohort of 100 consecutive patients. PLoS One2013; 8: e81509.
19.
HarisMGuptaRKSinghAet al.Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI. Neuroradiology2008; 50: 531–540.
20.
HouraniRBrantLJRizkTet al.Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?AJNR Am J Neuroradiol2008; 292: 366–372.
21.
KongLChenHYangYet al.A meta-analysis of arterial spin labelling perfusion values for the prediction of glioma grade. Clin Radiol2017; 72: 255–261.
22.
LiangRWangXLiMet al.Meta-analysis of peritumoural rCBV values derived from dynamic susceptibility contrast imaging in differentiating high-grade gliomas from intracranial metastases. Int J Clin Exp Med2014; 7: 2724–2729.
23.
BauerAHErlyWMoserFGet al.Differentiation of solitary brain metastasis from glioblastoma multiforme: A predictive multiparametric approach using combined MR diffusion and perfusion. Neuroradiology2015; 57: 697–703.
24.
ZhangMOlssonY. Hematogenous metastases of the human brain—Characteristics of peritumoral brain changes: A review. J Neurooncol1997; 35: 81–89.
25.
LinLXueYDuanQet al.The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions. Oncotarget2016; 7: 69051–69059.
26.
SunwooLYunTJYouSHet al.Differentiation of glioblastoma from brain metastasis: Qualitative and quantitative analysis using arterial spin labeling MR imaging. PloS One2016; 11: e0166662.
27.
LongDM. Capillary ultrastructure in human metastatic brain tumors. J Neurosurg1979; 51: 53–58.
28.
HossmanKABlöinkM. Blood flow and regulation of blood flow in experimental peritumoral edema. Stroke1981; 12: 211–217.
29.
BulakbasiNKocaogluMFarzaliyevAet al.Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol2005; 26: 2187–2199.
30.
BatraATripathiRP. Perfusion magnetic resonance imaging in intracerebral parenchymal tuberculosis: Preliminary findings. J Comput Assist Tomogr2003; 27: 882–888.
31.
GuptaRKHarisMHusainNet al.Relative cerebral blood volume is a measure of angiogenesis in brain tuberculoma. J Comput Assist Tomogr2007; 31: 335–341.
32.
HarisMGuptaRKHusainMet al.Assessment of therapeutic response in brain tuberculomas using serial dynamic contrast-enhanced MRI. Clin Radiol2008; 63: 562–574.
33.
GuptaRKAwasthiRGargRKet al.T1-weighted dynamic contrast-enhanced MR evaluation of different stages of neurocysticercosis and its relationship with serum MMP-9 expression. AJNR Am J Neuroradiol2013; 34: 997–1003.
34.
HolmesTMPetrellaJRProvenzaleJM. Distinction between cerebral abscesses and high-grade neoplasms by dynamic susceptibility contrast perfusion MRI. AJR Am J Roentgenol2004; 183: 1247–1252.
35.
ErdoganCHakyemezBYildirimNet al.Brain abscess and cystic brain tumor: Discrimination with dynamic susceptibility contrast perfusion-weighted MRI. J Comput Assist Tomogr2005; 29: 663–667.
36.
ChaSPierceSKnoppEAet al.Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol2001; 22: 1109–1116.
37.
BlaselSPfeilschifterWJansenVet al.Metabolism and regional cerebral blood volume in autoimmune inflammatory demyelinating lesions mimicking malignant gliomas. J Neurol2011; 258: 113–122.
38.
HiremathSBMuraleedharanAKumarSet al.Combining diffusion tensor metrics and DSC perfusion imaging: Can it improve the diagnostic accuracy in differentiating tumefactive demyelination from high-grade glioma?AJNR Am J Neuroradiol2017; 38: 685–690.
39.
YoungRBabbJLawMet al.Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. J Magn Reson Imaging2007; 26: 1053–1063.
40.
WetzelSGChaSJohnsonGet al.Relative cerebral blood volume measurements in intracranial mass lesions: Interobserver and intraobserver reproducibility study. Radiology2002; 224: 797–803.
41.
EmblemKENedregaardBNomeTet al.Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology2008; 247: 808–817.
42.
SoniNJainAKumarSet al.Arterial spin labeling magnetic resonance perfusion study to evaluate the effects of age and gender on normal cerebral blood flow. Neurol India2016; 64 (Suppl): S32–S38.
